Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related mortality.
The principal treatment is surgical resection or liver transplantation, depending on whether …

Purpose To describe outcomes of prospective trials of stereotactic body radiotherapy (SBRT)
for hepatocellular carcinoma (HCC). Patients and Methods Two trials of SBRT for patients …

Purpose To perform a systematic review and meta-analysis to compare the clinical
outcomes and toxicity of hepatocellular carcinoma (HCC) patients treated with charged …

Purpose To describe efficacy and safety of stereotactic body radiation therapy (SBRT) for the
treatment of inoperable hepatocellular carcinoma. Methods The records of 77 consecutive …

Introduction Surgery is the standard treatment for early stage non–small-cell lung cancer
(NSCLC). For medically inoperable patients, stereotactic ablative radiotherapy (SABR) has …

BACKGROUND: Stereotactic body radiation therapy (SBRT) has emerged as a potential
treatment option for local tumor control of primary malignancies of the pancreas. We report …

Background. An excess of 100 000 individuals are diagnosed with primary liver tumors
every year in USA but less than 20% of those patients are amenable to definitive surgical …

Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide, and its
incidence is on the rise. The primary therapy is resection or liver transplant, but only a …

The presence of tumor and organ motions complicates the planning and delivery of
radiotherapy for gastrointestinal cancers. Without proper accounting of the movements …

With increasing clinical use, radiotherapy (RT) has been considered reliable and effective
method for hepatocellular carcinoma (HCC) treatment, depending on extent of disease and …